Director/PDMR Shareholding (2567A)

TIDMHIK

RNS Number : 2567A

Hikma Pharmaceuticals Plc

28 March 2012

Hikma Pharmaceuticals PLC - Share Transactions

LONDON, 28 March 2012: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have exercised awards which vested on 19 March 2012 under the 2005 Long Term Incentive Plan ("LTIP"). The exercise price under the LTIP is GBPnil. The persons concerned elected to sell their shares as detailed below.

In accordance with DTR 3.1.2R and s.793 of the Companies Act 2006, Hikma announces that the following transactions took place in London over the Company's Ordinary Shares of 10p each as detailed below.

 
 PDMR                      Type of Transaction   Exercised      Date       Price     Shares Sold   Outstanding 
                                                                                                    Holding 
------------------------  --------------------  -------------  ---------  --------  ------------  ------------- 
 Bassam                    Exercise of           69,000         28 March   GBP6.91   30,000        418,568 
  Kanaan                    LTIP 2009                            2012 
                                                  (0.04% ISC)                                       (0.21% ISC) 
------------------------  --------------------  -------------  ---------  --------  ------------  ------------- 
 Michael                   Exercise of           46,000         28 March   GBP6.91   46,000        12,200 
  Raya                      LTIP 2009                            2012 
                                                  (0.02% ISC)                                       (0.01% ISC) 
------------------------  --------------------  -------------  ---------  --------  ------------  ------------- 
 Jason Grenfell-Gardener   Exercise of           27,600         28 March   GBP6.91   27,600        Nil 
                            LTIP 2009                            2012 
                                                  (0.01% ISC)                                       (0.00% ISC) 
------------------------  --------------------  -------------  ---------  --------  ------------  -------------

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC

   Henry Knowles                             +44 20 7399 2760

Company Secretary

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non--branded generic and in--licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2011, Hikma achieved revenue of $918.0 million and profit attributable to shareholders of $80.1 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBGGDXGBDBGDI

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024